![](/img/cover-not-exists.png)
PAR5 COST-EFFECTIVENESS OF RITUXIMAB AS A NEW TREATMENT MODALITY FOR RHEUMATOID ARTHRITIS IN GERMANY
A Rubbert, A Kielhorn, S Schach, B BrownVolume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)64386-0
File:
PDF, 65 KB
english, 2006